Cargando…
Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival
Given the survival benefits of adjuvant chemotherapy for advanced ovarian cancer (OC), we examined the associations of survival with the time interval from debulking surgery to initiation of chemotherapy and with the duration of chemotherapy. Among patients ⩾65 years with stages III/IV OC diagnosed...
Autores principales: | Wright, J D, Doan, T, McBride, R, Jacobson, J S, Hershman, D L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359630/ https://www.ncbi.nlm.nih.gov/pubmed/18349836 http://dx.doi.org/10.1038/sj.bjc.6604298 |
Ejemplares similares
-
Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016
por: Knisely, Anne T., et al.
Publicado: (2020) -
Predictors of survival after hepatic resection among patients with colorectal liver metastasis
por: Wang, X, et al.
Publicado: (2007) -
External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancer
por: van de Laar, R, et al.
Publicado: (2014) -
Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
por: Chung, Young Shin, et al.
Publicado: (2017) -
Ovarian Carcinosarcoma: Effects of Cytoreductive Status and Platinum-Based Chemotherapy on Survival
por: Jernigan, Amelia M., et al.
Publicado: (2013)